Response of the Department of Health and Human Services to NBAC's Report 'Research Involving Human Biological Materials: Ethical Issues and Policy Guidance'. Appendix

05/01/2001

Lily Engstrom, M.S., Chair
Office of Science Policy
Office of the Assistant Secretary for Planning and Evaluation

Carol Greene, M.D., Executive Secretary
Office of Science Policy
Office of the Assistant Secretary for Planning and Evaluation

William Freeman, M.D., M.P.H., C.I.P.
Director, IHS Research Program
Chair, IHS IRB
Indian Health Service

Paul W. Goebel, Jr.
(Formerly) Senior Education Coordinator
Office for Human Research Protections
Office of Public Health and Science

Penny Kyler, MA, OTR
Public Health Analyst, Genetic Services Branch
Maternal and Child Health Bureau
Health Resources and Services Administration

Annette Levey, J.D.
Senior Attorney, NIH Branch, Public Health Division
Office of the General Counsel

John Livengood, M.D., M. Phil.
Deputy Associate Director for Science
Centers for Disease Control and Prevention

Marian Linde-Serge, R.N.
Nurse Consultant, Office of Compliance
Center for Devices and Radiological Health
Food and Drug Administration

Marie Mann, M.D., M.P.H.
Deputy Chief, Genetic Services Branch
Maternal and Child Health Bureau
Health Resources and Services Administration

Malcolm Moos, M.D., Ph.D.
Medical Officer, Division of Cellular and Gene Therapies
Center for Biologics Evaluation and Research
Food and Drug Administration

Marva Moxey-Mims, M.D.
Medical Officer, Office of Device Evaluation
Center for Devices and Radiological Health
Food and Drug Administration

Philip Noguchi, M.D.
Director, Division of Cellular and Gene Therapies
Center for Biologics Evaluation and Research
Food and Drug Administration

Thomas Puglisi, Ph.D.
(Formerly) Director, Division of Policy and Assurance
Office for Human Research Protections
Office of Public Health and Science

Richard Riseberg, J.D.
Chief Counsel, U.S. Public Health Division
Office of the General Counsel

Susan Sherman, J.D., M.H.S.
Senior Attorney, Public Health Division
Office of the General Counsel

Mark E. Sobel, M.D., Ph.D.
(Formerly) Chief, Molecular Pathology Section, Laboratory of Pathology
National Cancer Institute
National Institutes of Health

The Working Group thanks John Fanning, L.L.B., Senior Policy Analyst, Office of the Assistant Secretary for Planning and Evaluation, Office of the Secretary, and Julie Kaneshiro, M.A., Policy Analyst, Office of Science Policy and Planning, Office of the Director, National Institutes of Health for providing important background information regarding the Privacy Act and the HIPAA medical privacy regulation.

View full report

Preview
Download

"hbm.pdf" (pdf, 549.86Kb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®